Complement C5a receptor-mediated signaling may be involved in neurodegeneration in Alzheimer's disease
- PMID: 12759460
- DOI: 10.4049/jimmunol.170.11.5764
Complement C5a receptor-mediated signaling may be involved in neurodegeneration in Alzheimer's disease
Abstract
In our earlier results, we demonstrated that cells expressing the complement C5aR are vulnerable since abnormal activation of C5aR caused apoptosis of these cells. In this study, we demonstrate that activation of C5aR by antisense homology box (AHB) peptides synthesized in multiple antigenic peptide form and representing putative interaction sites of the C5a/C5aR evoked calcium influx in TGW neuroblastoma cells. Dose-dependent inhibition of the response was found when the cells were pretreated with C5a, suggesting that C5aR was involved in this process. In addition, pretreatment with monomeric forms of the AHB peptides resulted in attenuation of the calcium signals, supporting the idea of the role of C5aR in this process. Cells of a neuron-rich primary culture and pyramidal cells of rat brain slices also responded to the AHB peptide activation with an increase in the intracellular calcium level, showing that calcium metabolism might be affected in these cells. TUNEL staining demonstrated that C5aR-mediated apoptosis could be induced both in cells of the primary culture as well as in cortical pyramidal neurons of the rat brain. In addition, we investigated expression of C5aR in the hippocampal and cortical neurons of human brains of healthy and demented patients using two anti-human C5aR Abs. Pyramidal cells of the hippocampus and cortex and granular cells of the hippocampus were immunopositive on staining. Although staining was also positive in the vascular dementia brain, it disappeared in the brain with Alzheimer's disease. These results provide further support that C5aR may be involved in neurodegeneration.
Similar articles
-
Neuronal expression of a functional receptor for the C5a complement activation fragment.J Immunol. 2001 Mar 15;166(6):4154-62. doi: 10.4049/jimmunol.166.6.4154. J Immunol. 2001. PMID: 11238666
-
A neuronal C5a receptor and an associated apoptotic signal transduction pathway.J Physiol. 1998 Mar 15;507 ( Pt 3)(Pt 3):679-87. doi: 10.1111/j.1469-7793.1998.679bs.x. J Physiol. 1998. PMID: 9508829 Free PMC article.
-
Complement C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells.Neuroscience. 1998 Oct;86(3):903-11. doi: 10.1016/s0306-4522(98)00108-0. Neuroscience. 1998. PMID: 9692726
-
Expression of the anaphylatoxin C5a receptor in non-myeloid cells.Mol Immunol. 1999 Sep-Oct;36(13-14):877-84. doi: 10.1016/s0161-5890(99)00109-1. Mol Immunol. 1999. PMID: 10698342 Review.
-
Functions of anaphylatoxin C5a in rat liver: direct and indirect actions on nonparenchymal and parenchymal cells.Int Immunopharmacol. 2001 Mar;1(3):469-81. doi: 10.1016/s1567-5769(00)00038-2. Int Immunopharmacol. 2001. PMID: 11367531 Review.
Cited by
-
Gangliosides play pivotal roles in the regulation of complement systems and in the maintenance of integrity in nerve tissues.Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22405-10. doi: 10.1073/pnas.0912336106. Epub 2009 Dec 11. Proc Natl Acad Sci U S A. 2009. PMID: 20018737 Free PMC article.
-
Complement activation and increased anaphylatoxin receptor expression are associated with cortical grey matter lesions and the compartmentalised inflammatory response of multiple sclerosis.Front Cell Neurosci. 2023 Mar 22;17:1094106. doi: 10.3389/fncel.2023.1094106. eCollection 2023. Front Cell Neurosci. 2023. PMID: 37032838 Free PMC article.
-
Periodontitis, Microbiomes and their Role in Alzheimer's Disease.Front Aging Neurosci. 2017 Oct 24;9:336. doi: 10.3389/fnagi.2017.00336. eCollection 2017. Front Aging Neurosci. 2017. PMID: 29114218 Free PMC article.
-
The role of the complement system and the activation fragment C5a in the central nervous system.Neuromolecular Med. 2010 Jun;12(2):179-92. doi: 10.1007/s12017-009-8085-y. Epub 2009 Sep 11. Neuromolecular Med. 2010. PMID: 19763906
-
Targeting the Complement-Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy.Int J Mol Sci. 2022 Nov 18;23(22):14340. doi: 10.3390/ijms232214340. Int J Mol Sci. 2022. PMID: 36430817 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical